{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:18:02Z","timestamp":1790691482732,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000957","name":"Alzheimer&apos;s Association","doi-asserted-by":"publisher","award":["AACSFD-22-922844"],"award-info":[{"award-number":["AACSFD-22-922844"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2021MH005, ZR2023QH206 and ZR2023QH212"],"award-info":[{"award-number":["ZR2021MH005, ZR2023QH206 and ZR2023QH212"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171175"],"award-info":[{"award-number":["82171175"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Plasma amyloid-\u03b2(A\u03b2)42\/40 ratio, glial fibrillary acidic protein (GFAP), neurofilament light (NfL), and phosphorylated tau181(p-tau181) are promising biomarkers for Alzheimer\u2019s disease (AD)-related pathology. We aimed to explore the longitudinal trajectories of these biomarkers in association with changes in structural brain markers and cognition, and the impact of cognitive reserve on their associations with cognitive function. This cohort study included 1270 individuals (mean age 59.7 years; 58.9% women) derived from the UK Biobank who had data on plasma biomarkers available at baseline (2014\u20132020); of these, data were available in 904 individuals for brain MRI scans and in 1183 for cognitive function. In 2021\u20132022, follow-up brain MRI markers and cognitive function were assessed. Plasma A\u03b2, GFAP, NfL, and p-tau181 were quantified using single-molecule array technology. Brain MRI scans were used to assess atrophic brain measures and white matter microstructures. Cognitive reserve was indexed by education, with college degree or above being defined as high cognitive reserve. Higher baseline plasma GFAP and NfL were significantly associated with brain atrophy and impaired white matter microstructure. The longitudinal increase in plasma GFAP was correlated with accelerated deterioration in processing speed (\u03b2\u2009=\u2009\u22120.041,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.002) and visual attention (\u03b2\u2009=\u2009\u22120.048,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.001), and with impaired white matter microstructure. Importantly, high cognitive reserve significantly mitigated the association between increases in plasma GFAP and NfL and accelerated decline in processing speed. These results indicate that plasma GFAP and NfL are surrogate biomarkers for structural brain health and cognitive health, and that high cognitive reserve may modify the cognitive trajectories associated with Alzheimer\u2019s pathology.\n                  <\/jats:p>","DOI":"10.1038\/s41380-025-03166-y","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T10:02:59Z","timestamp":1756375379000},"page":"749-760","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Associations between trajectories of plasma biomarkers for Alzheimer\u2019s disease, brain structures, and cognitive function: a prospective cohort study in the UK Biobank"],"prefix":"10.1038","volume":"31","author":[{"given":"Xin","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongli","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahao","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuewei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanjun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minle","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1881-0939","authenticated-orcid":false,"given":"Yanping","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifeng","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1922-4912","authenticated-orcid":false,"given":"Chengxuan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0742-9072","authenticated-orcid":false,"given":"Lin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8832-7301","authenticated-orcid":false,"given":"Yongxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,28]]},"reference":[{"key":"3166_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","volume":"8","author":"BT Hyman","year":"2012","unstructured":"Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC, et al. National institute on aging-Alzheimer\u2019s association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease. Alzheimers Dement. 2012;8:1\u201313.","journal-title":"Alzheimers Dement"},{"key":"3166_CR2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S1474-4422(21)00361-6","volume":"21","author":"CE Teunissen","year":"2022","unstructured":"Teunissen CE, Verberk IMW, Thijssen EH, Vermunt L, Hansson O, Zetterberg H, et al. Blood-based biomarkers for Alzheimer\u2019s disease: towards clinical implementation. Lancet Neurol. 2022;21:66\u201377.","journal-title":"Lancet Neurol"},{"key":"3166_CR3","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1001\/jamaneurol.2019.1632","volume":"76","author":"S Palmqvist","year":"2019","unstructured":"Palmqvist S, Janelidze S, Stomrud E, Zetterberg H, Karl J, Zink K, et al. Performance of fully automated plasma assays as screening tests for Alzheimer disease-related \u03b2-amyloid status. JAMA Neurol. 2019;76:1060\u20139.","journal-title":"JAMA Neurol"},{"key":"3166_CR4","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41591-020-0755-1","volume":"26","author":"S Janelidze","year":"2020","unstructured":"Janelidze S, Mattsson N, Palmqvist S, Smith R, Beach TG, Serrano GE, et al. Plasma P-tau181 in Alzheimer\u2019s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer\u2019s dementia. Nat Med. 2020;26:379\u201386.","journal-title":"Nat Med"},{"key":"3166_CR5","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S1474-4422(20)30137-X","volume":"19","author":"YT Quiroz","year":"2020","unstructured":"Quiroz YT, Zetterberg H, Reiman EM, Chen Y, Su Y, Fox-Fuller JT, et al. Plasma neurofilament light chain in the presenilin 1 E280A autosomal dominant Alzheimer\u2019s disease kindred: a cross-sectional and longitudinal cohort study. Lancet Neurol. 2020;19:513\u201321.","journal-title":"Lancet Neurol"},{"key":"3166_CR6","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/alz.12724","volume":"19","author":"P Chatterjee","year":"2023","unstructured":"Chatterjee P, Pedrini S, Doecke JD, Thota R, Villemagne VL, Dor\u00e9 V, et al. Plasma A\u03b242\/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer\u2019s disease continuum: A cross-sectional and longitudinal study in the AIBL cohort. Alzheimers Dement. 2023;19:1117\u201334.","journal-title":"Alzheimers Dement"},{"key":"3166_CR7","doi-asserted-by":"publisher","first-page":"e2028634","DOI":"10.1001\/jamanetworkopen.2020.28634","volume":"3","author":"KV Giudici","year":"2020","unstructured":"Giudici KV, de Souto Barreto P, Guyonnet S, Li Y, Bateman RJ, Vellas B. Assessment of plasma amyloid-\u03b242\/40 and cognitive decline among community-dwelling older adults. JAMA Netw Open. 2020;3:e2028634.","journal-title":"JAMA Netw Open"},{"key":"3166_CR8","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science. 2002;297:353\u20136.","journal-title":"Science"},{"key":"3166_CR9","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3233\/JAD-140771","volume":"43","author":"P Lewczuk","year":"2015","unstructured":"Lewczuk P, Lelental N, Spitzer P, Maler JM, Kornhuber J. Amyloid-\u03b2 42\/40 cerebrospinal fluid concentration ratio in the diagnostics of Alzheimer\u2019s disease: validation of two novel assays. J Alzheimers Dis. 2015;43:183\u201391.","journal-title":"J Alzheimers Dis"},{"key":"3166_CR10","doi-asserted-by":"publisher","first-page":"e1647","DOI":"10.1212\/WNL.0000000000008081","volume":"93","author":"SE Schindler","year":"2019","unstructured":"Schindler SE, Bollinger JG, Ovod V, Mawuenyega KG, Li Y, Gordon BA, et al. High-precision plasma \u03b2-amyloid 42\/40 predicts current and future brain amyloidosis. Neurology. 2019;93:e1647\u201359.","journal-title":"Neurology"},{"key":"3166_CR11","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41582-021-00616-3","volume":"18","author":"A Abdelhak","year":"2022","unstructured":"Abdelhak A, Foschi M, Abu-Rumeileh S, Yue JK, D\u2019Anna L, Huss A, et al. Blood GFAP as an emerging biomarker in brain and spinal cord disorders. Nat Rev Neurol. 2022;18:158\u201372.","journal-title":"Nat Rev Neurol"},{"key":"3166_CR12","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1093\/brain\/awac328","volume":"146","author":"S Abu-Rumeileh","year":"2023","unstructured":"Abu-Rumeileh S, Abdelhak A, Foschi M, D\u2019Anna L, Russo M, Steinacker P, et al. The multifaceted role of neurofilament light chain protein in non-primary neurological diseases. Brain. 2023;146:421\u201337.","journal-title":"Brain"},{"key":"3166_CR13","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41591-018-0304-3","volume":"25","author":"O Preische","year":"2019","unstructured":"Preische O, Schultz SA, Apel A, Kuhle J, Kaeser SA, Barro C, et al. Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer\u2019s disease. Nat Med. 2019;25:277\u201383.","journal-title":"Nat Med"},{"key":"3166_CR14","volume":"16","author":"JR Chong","year":"2024","unstructured":"Chong JR, Chai YL, Yam ATY, Hilal S, Vrooman H, Venketasubramanian N, et al. Association of plasma GFAP with elevated brain amyloid is dependent on severity of white matter lesions in an Asian cognitively impaired cohort. Alzheimers Dement. 2024;16:e12576.","journal-title":"Alzheimers Dement"},{"key":"3166_CR15","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","volume":"12","author":"CR Jack Jr.","year":"2013","unstructured":"Jack CR Jr., Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, et al. Tracking pathophysiological processes in Alzheimer\u2019s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013;12:207\u201316.","journal-title":"Lancet Neurol"},{"key":"3166_CR16","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/S1474-4422(12)70191-6","volume":"11","author":"Y Stern","year":"2012","unstructured":"Stern Y. Cognitive reserve in ageing and Alzheimer\u2019s disease. Lancet Neurol. 2012;11:1006\u201312.","journal-title":"Lancet Neurol"},{"key":"3166_CR17","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.jalz.2018.07.219","volume":"16","author":"Y Stern","year":"2020","unstructured":"Stern Y, Arenaza-Urquijo EM, Bartr\u00e9s-Faz D, Belleville S, Cantilon M, Chetelat G, et al. Whitepaper: defining and investigating cognitive reserve, brain reserve, and brain maintenance. Alzheimers Dement. 2020;16:1305\u201311.","journal-title":"Alzheimers Dement"},{"key":"3166_CR18","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","volume":"404","author":"G Livingston","year":"2024","unstructured":"Livingston G, Huntley J, Liu KY, Costafreda SG, Selb\u00e6k G, Alladi S, et al. Dementia prevention, intervention, and care: 2024 report of the lancet standing commission. Lancet. 2024;404:572\u2013628.","journal-title":"Lancet"},{"key":"3166_CR19","doi-asserted-by":"publisher","first-page":"e1695","DOI":"10.1212\/WNL.0000000000012728","volume":"97","author":"X Li","year":"2021","unstructured":"Li X, Song R, Qi X, Xu H, Yang W, Kivipelto M, et al. Influence of cognitive reserve on cognitive trajectories: role of brain pathologies. Neurology. 2021;97:e1695\u20131706.","journal-title":"Neurology"},{"key":"3166_CR20","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/nn.4393","volume":"19","author":"KL Miller","year":"2016","unstructured":"Miller KL, Alfaro-Almagro F, Bangerter NK, Thomas DL, Yacoub E, Xu J, et al. Multimodal population brain imaging in the UK Biobank prospective epidemiological study. Nat Neurosci. 2016;19:1523\u201336.","journal-title":"Nat Neurosci"},{"key":"3166_CR21","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12:e1001779.","journal-title":"PLoS Med"},{"key":"3166_CR22","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41562-020-01027-y","volume":"5","author":"G Aydogan","year":"2021","unstructured":"Aydogan G, Daviet R, Karlsson Linn\u00e9r R, Hare TA, Kable JW, Kranzler HR, et al. Genetic underpinnings of risky behaviour relate to altered neuroanatomy. Nat Hum Behav. 2021;5:787\u201394.","journal-title":"Nat Hum Behav"},{"key":"3166_CR23","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.neuroimage.2012.03.072","volume":"61","author":"H Zhang","year":"2012","unstructured":"Zhang H, Schneider T, Wheeler-Kingshott CA, Alexander DC. NODDI: practical in vivo neurite orientation dispersion and density imaging of the human brain. Neuroimage. 2012;61:1000\u201316.","journal-title":"Neuroimage"},{"key":"3166_CR24","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","volume":"622","author":"BB Sun","year":"2023","unstructured":"Sun BB, Chiou J, Traylor M, Benner C, Hsu YH, Richardson TG, et al. Plasma proteomic associations with genetics and health in the UK Biobank. Nature. 2023;622:329\u201338.","journal-title":"Nature"},{"key":"3166_CR25","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41586-023-06547-x","volume":"622","author":"RS Dhindsa","year":"2023","unstructured":"Dhindsa RS, Burren OS, Sun BB, Prins BP, Matelska D, Wheeler E, et al. Rare variant associations with plasma protein levels in the UK Biobank. Nature. 2023;622:339\u201347.","journal-title":"Nature"},{"key":"3166_CR26","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1093\/ije\/dym276","volume":"37","author":"P Elliott","year":"2008","unstructured":"Elliott P, Peakman TC. The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine. Int J Epidemiol. 2008;37:234\u201344.","journal-title":"Int J Epidemiol"},{"key":"3166_CR27","doi-asserted-by":"publisher","first-page":"e0231627","DOI":"10.1371\/journal.pone.0231627","volume":"15","author":"C Fawns-Ritchie","year":"2020","unstructured":"Fawns-Ritchie C, Deary IJ. Reliability and validity of the UK Biobank cognitive tests. PLoS ONE. 2020;15:e0231627.","journal-title":"PLoS ONE"},{"key":"3166_CR28","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.neuroimage.2017.10.034","volume":"166","author":"F Alfaro-Almagro","year":"2018","unstructured":"Alfaro-Almagro F, Jenkinson M, Bangerter NK, Andersson JLR, Griffanti L, Douaud G, et al. Image processing and quality control for the first 10,000 brain imaging datasets from UK Biobank. Neuroimage. 2018;166:400\u201324.","journal-title":"Neuroimage"},{"key":"3166_CR29","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/mp.2016.45","volume":"21","author":"G Davies","year":"2016","unstructured":"Davies G, Marioni RE, Liewald DC, Hill WD, Hagenaars SP, Harris SE, et al. Genome-wide association study of cognitive functions and educational attainment in UK Biobank (N=112\u2009151). Mol Psychiatry. 2016;21:758\u201367.","journal-title":"Mol Psychiatry"},{"key":"3166_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102954","volume":"59","author":"AL Lumsden","year":"2020","unstructured":"Lumsden AL, Mulugeta A, Zhou A, Hypp\u00f6nen E. Apolipoprotein E (APOE) genotype-associated disease risks: a phenome-wide, registry-based, case-control study utilising the UK Biobank. EBioMedicine. 2020;59:102954.","journal-title":"EBioMedicine"},{"key":"3166_CR31","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft C, Freeman C, Petkova D, Band G, Elliott LT, Sharp K, et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562:203\u20139.","journal-title":"Nature"},{"key":"3166_CR32","doi-asserted-by":"publisher","first-page":"e1003830","DOI":"10.1371\/journal.pmed.1003830","volume":"18","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Yang H, Li S, Li WD, Wang Y. Consumption of coffee and tea and risk of developing stroke, dementia, and poststroke dementia: a cohort study in the UK Biobank. PLoS Med. 2021;18:e1003830.","journal-title":"PLoS Med"},{"key":"3166_CR33","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1002\/alz.13521","volume":"20","author":"H Chen","year":"2024","unstructured":"Chen H, Dunk MM, Wang B, Zhao M, Shen J, Zong G, et al. Associations of the mediterranean-DASH intervention for neurodegenerative delay diet with brain structural markers and their changes. Alzheimers Dement. 2024;20:1190\u2013200.","journal-title":"Alzheimers Dement"},{"key":"3166_CR34","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1002\/ana.25874","volume":"88","author":"KB Rajan","year":"2020","unstructured":"Rajan KB, Aggarwal NT, McAninch EA, Weuve J, Barnes LL, Wilson RS, et al. Remote blood biomarkers of longitudinal cognitive outcomes in a population study. Ann Neurol. 2020;88:1065\u201376.","journal-title":"Ann Neurol"},{"key":"3166_CR35","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1136\/jnnp.2010.205757","volume":"81","author":"TT Sepp\u00e4l\u00e4","year":"2010","unstructured":"Sepp\u00e4l\u00e4 TT, Herukka SK, H\u00e4nninen T, Tervo S, Hallikainen M, Soininen H, et al. Plasma Abeta42 and Abeta40 as markers of cognitive change in follow-up: a prospective, longitudinal, population-based cohort study. J Neurol Neurosurg Psychiatry. 2010;81:1123\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3166_CR36","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1001\/jamaneurol.2021.4222","volume":"79","author":"MC Gonzalez","year":"2022","unstructured":"Gonzalez MC, Ashton NJ, Gomes BF, Tovar-Rios DA, Blanc F, Karikari TK, et al. Association of plasma p-tau181 and p-tau231 concentrations with cognitive decline in patients with probable dementia with lewy bodies. JAMA Neurol. 2022;79:32\u201337.","journal-title":"JAMA Neurol"},{"key":"3166_CR37","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S1474-4422(20)30071-5","volume":"19","author":"TK Karikari","year":"2020","unstructured":"Karikari TK, Pascoal TA, Ashton NJ, Janelidze S, Benedet AL, Rodriguez JL, et al. Blood phosphorylated tau 181 as a biomarker for Alzheimer\u2019s disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts. Lancet Neurol. 2020;19:422\u201333.","journal-title":"Lancet Neurol"},{"key":"3166_CR38","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1001\/jamaneurol.2019.0765","volume":"76","author":"N Mattsson","year":"2019","unstructured":"Mattsson N, Cullen NC, Andreasson U, Zetterberg H, Blennow K. Association between longitudinal plasma neurofilament light and neurodegeneration in patients with Alzheimer disease. JAMA Neurol. 2019;76:791\u20139.","journal-title":"JAMA Neurol"},{"key":"3166_CR39","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14:535\u201362.","journal-title":"Alzheimers Dement"},{"key":"3166_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34084-0","volume":"13","author":"W Zhang","year":"2022","unstructured":"Zhang W, Xie Y, Yang T. Reward salience but not spatial attention dominates the value representation in the orbitofrontal cortex. Nat Commun. 2022;13:6306.","journal-title":"Nat Commun"},{"key":"3166_CR41","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1093\/brain\/awab163","volume":"144","author":"JB Pereira","year":"2021","unstructured":"Pereira JB, Janelidze S, Stomrud E, Palmqvist S, van Westen D, Dage JL, et al. Plasma markers predict changes in amyloid, tau, atrophy and cognition in non-demented subjects. Brain. 2021;144:2826\u201336.","journal-title":"Brain"},{"key":"3166_CR42","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1001\/jamaneurol.2020.4986","volume":"78","author":"A Moscoso","year":"2021","unstructured":"Moscoso A, Grothe MJ, Ashton NJ, Karikari TK, Lantero Rodr\u00edguez J, Snellman A, et al. Longitudinal associations of blood phosphorylated tau181 and neurofilament light chain with neurodegeneration in Alzheimer disease. JAMA Neurol. 2021;78:396\u2013406.","journal-title":"JAMA Neurol"},{"key":"3166_CR43","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1002\/alz.12283","volume":"17","author":"J Simr\u00e9n","year":"2021","unstructured":"Simr\u00e9n J, Leuzy A, Karikari TK, Hye A, Benedet AL, Lantero-Rodriguez J, et al. The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer\u2019s disease. Alzheimers Dement. 2021;17:1145\u201356.","journal-title":"Alzheimers Dement"},{"key":"3166_CR44","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1093\/brain\/awaa342","volume":"143","author":"AL Benedet","year":"2020","unstructured":"Benedet AL, Leuzy A, Pascoal TA, Ashton NJ, Mathotaarachchi S, Savard M, et al. Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer\u2019s disease. Brain. 2020;143:3793\u2013804.","journal-title":"Brain"},{"key":"3166_CR45","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13195-021-00802-x","volume":"13","author":"C Tissot","year":"2021","unstructured":"Tissot C, L Benedet A, Therriault J, Pascoal TA, Lussier FZ, Saha-Chaudhuri P, et al. Plasma pTau181 predicts cortical brain atrophy in aging and Alzheimer\u2019s disease. Alzheimers Res Ther. 2021;13:69.","journal-title":"Alzheimers Res Ther"},{"key":"3166_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropsychologia.2022.108414","volume":"177","author":"J Zhao","year":"2022","unstructured":"Zhao J, Song Z, Zhao Y, Thiebaut de Schotten M, Altarelli I, Ramus F. White matter connectivity in uncinate fasciculus accounts for visual attention span in developmental dyslexia. Neuropsychologia. 2022;177:108414.","journal-title":"Neuropsychologia"},{"key":"3166_CR47","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3390\/brainsci9120377","volume":"9","author":"CH Park","year":"2019","unstructured":"Park CH, Kim SH, Jung HY. Characteristics of the uncinate fasciculus and cingulum in patients with mild cognitive impairment: diffusion tensor tractography study. Brain Sci. 2019;9:377.","journal-title":"Brain Sci"},{"key":"3166_CR48","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1007\/s13760-020-01322-5","volume":"121","author":"L Qin","year":"2021","unstructured":"Qin L, Guo Z, McClure MA, Mu Q. White matter changes from mild cognitive impairment to Alzheimer\u2019s disease: a meta-analysis. Acta Neurol Belg. 2021;121:1435\u201347.","journal-title":"Acta Neurol Belg"},{"key":"3166_CR49","doi-asserted-by":"publisher","first-page":"2322.e2325","DOI":"10.1016\/j.neurobiolaging.2010.05.019","volume":"32","author":"CE Sexton","year":"2011","unstructured":"Sexton CE, Kalu UG, Filippini N, Mackay CE, Ebmeier KP. A meta-analysis of diffusion tensor imaging in mild cognitive impairment and Alzheimer\u2019s disease. Neurobiol Aging. 2011;32:2322.e2325\u201318.","journal-title":"Neurobiol Aging"},{"key":"3166_CR50","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/ana.21904","volume":"67","author":"DM Rentz","year":"2010","unstructured":"Rentz DM, Locascio JJ, Becker JA, Moran EK, Eng E, Buckner RL, et al. Cognition, reserve, and amyloid deposition in normal aging. Ann Neurol. 2010;67:353\u201364.","journal-title":"Ann Neurol"},{"key":"3166_CR51","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1001\/jama.2010.1995","volume":"305","author":"K Yaffe","year":"2011","unstructured":"Yaffe K, Weston A, Graff-Radford NR, Satterfield S, Simonsick EM, Younkin SG, et al. Association of plasma beta-amyloid level and cognitive reserve with subsequent cognitive decline. JAMA. 2011;305:261\u20136.","journal-title":"JAMA"},{"key":"3166_CR52","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/ana.10262","volume":"52","author":"G Kempermann","year":"2002","unstructured":"Kempermann G, Gast D, Gage FH. Neuroplasticity in old age: sustained fivefold induction of hippocampal neurogenesis by long-term environmental enrichment. Ann Neurol. 2002;52:135\u201343.","journal-title":"Ann Neurol"},{"key":"3166_CR53","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.neurobiolaging.2019.03.022","volume":"83","author":"Y Stern","year":"2019","unstructured":"Stern Y, Barnes CA, Grady C, Jones RN, Raz N. Brain reserve, cognitive reserve, compensation, and maintenance: operationalization, validity, and mechanisms of cognitive resilience. Neurobiol Aging. 2019;83:124\u20139.","journal-title":"Neurobiol Aging"},{"key":"3166_CR54","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/aje\/kwx246","volume":"186","author":"A Fry","year":"2017","unstructured":"Fry A, Littlejohns TJ, Sudlow C, Doherty N, Adamska L, Sprosen T, et al. Comparison of sociodemographic and health-related characteristics of UK Biobank participants with those of the general population. Am J Epidemiol. 2017;186:1026\u201334.","journal-title":"Am J Epidemiol"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-03166-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-03166-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-03166-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T19:02:42Z","timestamp":1768849362000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-03166-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,28]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["3166"],"URL":"https:\/\/doi.org\/10.1038\/s41380-025-03166-y","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,28]]},"assertion":[{"value":"15 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The research involving human participants was reviewed and approved by the UK Biobank, which holds ethical approval from several bodies: the North West Multi-center Research Ethics Committee for the UK, the National Information Governance Board for Health and Social Care for England and Wales, and the Community Health Index Advisory Group for Scotland. Participants provided informed consent through a touchscreen interface, confirming their agreement with each statement on the consent form and signing electronically. As per national regulations and institutional guidelines, written consent was not required for participation in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}